Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies
- 6 May 2008
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Cardiovascular Medicine
- Vol. 5 (6) , 338-349
Abstract
Endothelial cells control vascular homeostasis by generating paracrine factors that regulate vascular tone, inhibit platelet function, prevent adhesion of leukocytes, and limit proliferation of vascular smooth muscle. The dominant factor responsible for many of those effects is endothelium-derived nitric oxide (NO). Endothelial dysfunction characterized by enhanced inactivation or reduced synthesis of NO, alone or in combination, is seen in conjunction with risk factors for cardiovascular disease. Endothelial dysfunction can promote vasospasm, thrombosis, vascular inflammation, and proliferation of the intima. Vascular oxidative stress and increased production of reactive oxygen species contributes to mechanisms of vascular dysfunction. Oxidative stress is mainly caused by an imbalance between the activity of endogenous pro-oxidative enzymes (such as NADPH oxidase, xanthine oxidase or the mitochondrial respiratory chain) and antioxidant enzymes (such as superoxide dismutase, glutathione peroxidase, heme oxygenase, thioredoxin peroxidase/peroxiredoxin, catalase and paraoxonase). In addition, small-molecular-weight antioxidants might have a role in the defense against oxidative stress. Increased concentrations of reactive oxygen species reduce bioactive NO through chemical inactivation, forming toxic peroxynitrite, which in turn can uncouple endothelial NO synthase to form a dysfunctional superoxide-generating enzyme that contributes further to oxidative stress. The role of oxidative stress in vascular dysfunction and atherogenesis, and strategies for its prevention are discussed.Keywords
This publication has 84 references indexed in Scilit:
- Deficiency of Glutathione Peroxidase-1 Accelerates the Progression of Atherosclerosis in Apolipoprotein E-Deficient MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- NO Modulates NADPH Oxidase Function Via Heme Oxygenase-1 in Human Endothelial CellsHypertension, 2006
- Vascular effects of a common gene variant of extracellular superoxide dismutase in heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Endothelial Nitric Oxide Synthase in Vascular DiseaseCirculation, 2006
- Vascular Hypertrophy in Angiotensin II–Induced Hypertension Is Mediated by Vascular Smooth Muscle Cell–Derived H 2 O 2Hypertension, 2005
- Heme Oxygenase and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Oxidative Stress in Arterial HypertensionHypertension, 2001
- HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen SpeciesHypertension, 2001
- How does ascorbic acid prevent endothelial dysfunction?Free Radical Biology and Medicine, 2000